ClinicalTrials.Veeva

Menu

Assessment of MDD Management in Andalusia (PismaEP)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

MDD Management Strategies

Study type

Observational

Funder types

Industry

Identifiers

NCT01510886
PismaEP
NIS-NES-XXX-2011/3

Details and patient eligibility

About

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

Full description

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Enrollment

5,309 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • MDD Diagnosis Participants of the PismaEP study 18 yo. or older

Exclusion criteria

  • No specific exclusion criteria

Trial design

5,309 participants in 1 patient group

1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems